Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
03 May 2024
Events
Takeaways from the Trenches: the JetBlue/Spirit Merger Trial
Foley Partner Ben Dryden will moderate a panel for the ABA State Enforcement and the Mergers and Acquisitions Committees as they host a panel consisting of both enforcers and private practitioners, who will discuss the JetBlue/Spirit merger and what this decision may mean for the future of merger enforcement, including in the airline industry.
02 May 2024
Events
FTC Ban on Noncompetes – Final Rule and What It Means for Your Company and Your Clients
Foley Partner Ben Dryden will join a panel of attorneys to discuss the FTC’s recent rule on noncompete agreements, hosted by the Practising Law Institute.
25 April 2024
On Trial
A Trial Lawyer’s Trial Lawyer: Paul Callan On Trial
In this episode of On Trial, host Christopher DeGennaro sits down with seasoned trial lawyer and CNN legal commentator Paul Callan, former deputy chief of the Brooklyn District Attorney’s Office, with 30 years’ experience as a trial lawyer.